Literature DB >> 24022516

Artery phantoms for intravascular optical coherence tomography: diseased arteries.

Charles-Étienne Bisaillon, Guy Lamouche.   

Abstract

We propose and test various strategies for the creation of artery phantoms mimicking different kinds of diseased arteries when imaged by intravascular optical coherence tomography (IVOCT). We first review the method for making healthy artery phantoms. We then describe the procedure to fabricate diseased artery phantoms with intima thickening, lipid pool, thin-capped fibroatheroma, calcification, and restenosis (homogeneous and layered) after stent apposition. For each case, a phantom is fabricated, an IVOCT image is obtained, and the image is compared to that of a real artery.

Entities:  

Mesh:

Year:  2013        PMID: 24022516     DOI: 10.1117/1.JBO.18.9.096010

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  4 in total

1.  Three-dimensional, distendable bladder phantom for optical coherence tomography and white light cystoscopy.

Authors:  Kristen L Lurie; Gennifer T Smith; Saara A Khan; Joseph C Liao; Audrey K Ellerbee
Journal:  J Biomed Opt       Date:  2014-03       Impact factor: 3.170

2.  Multimodal 3D cancer-mimicking optical phantom.

Authors:  Gennifer T Smith; Kristen L Lurie; Dimitar V Zlatev; Joseph C Liao; Audrey K Ellerbee Bowden
Journal:  Biomed Opt Express       Date:  2016-01-25       Impact factor: 3.732

3.  Tissue-like phantoms for quantitative birefringence imaging.

Authors:  Xinyu Liu; Kathy Beaudette; Xianghong Wang; Linbo Liu; Brett E Bouma; Martin Villiger
Journal:  Biomed Opt Express       Date:  2017-09-12       Impact factor: 3.732

4.  Micron resolution, high-fidelity three-dimensional vascular optical imaging phantoms.

Authors:  Callum D Little; Radhika K Poduval; Richard Caulfield; Sacha Noimark; Richard J Colchester; Chris D Loder; Manish K Tiwari; Roby D Rakhit; Ioannis Papakonstantinou; Adrien E Desjardins
Journal:  J Biomed Opt       Date:  2019-02       Impact factor: 3.170

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.